Nominee Director Italy: Legal Structure, Costs & UBO Register

Nominee director services in Italy are legal — but since October 2023, they no longer provide anonymity from Italian authorities. They provide commercial privacy, a local management presence, and regulatory compliance — which remains commercially valuable, but is fundamentally different from what many foreign founders expect when they search for "nominee director Italy."

Most competitor pages on this topic were written before Italy's mandatory Registro dei Titolari Effettivi (UBO Register — Register of Beneficial Owners) became operational in October 2023. They present nominee arrangements as providing regulatory anonymity that Italian law no longer permits. Relying on that outdated picture creates serious compliance exposure. Using an unlicensed individual nominee for share-holding — rather than a MIMIT (Ministero delle Imprese e del Made in Italy — Ministry of Enterprises and Made in Italy)-licensed società fiduciaria (licensed trust company) — is another common and expensive mistake that generic guides fail to flag.

This post-October-2023 guide explains what nominee director and shareholder services genuinely deliver, what they cannot provide, the critical legal distinction between licensed and unlicensed arrangements, realistic all-in costs, and the banking timeline you must plan for. Our lawyers in Milan, Rome, and Florence structure compliant nominee arrangements for foreign entrepreneurs navigating the post-2023 Italian AML (anti-money laundering) framework.

What Nominee Services DO and DON'T Provide in Italy

Setting accurate expectations before engagement prevents the most common and costly misconceptions about Italian nominee structures.

The core message for 2024–2025: the value of Italian nominee services is commercial privacy and local management capability — not regulatory anonymity. Both are legitimate business needs; the second is simply not available under Italian or EU law regardless of how a nominee structure is drafted.

Commercial privacy means your name does not appear in commercial databases used by competitors, journalists, or commercial counterparties. It does not mean Italian authorities do not know who controls the company. Regulatory anonymity — hiding beneficial ownership from state authorities — is prohibited under EU AML law and Italian implementing legislation.

Since October 2023 — Italy's Mandatory UBO Register

The Registro dei Titolari Effettivi became operational in October 2023, implementing the Decreto 11 marzo 2022 that transposed EU AML Directive requirements into Italian law. This single development makes every guide to Italian nominee services published before late 2023 materially incomplete and potentially misleading.

Every Italian company (SRL, SpA, and similar legal entities), trust, and similar structure with Italian management must file UBO information with MIMIT via the Registro delle Imprese (Business Register) within 30 days of company formation, and within 30 days of any change in beneficial ownership.

Who must be disclosed: All natural persons who hold directly or indirectly more than 25% of shares or voting rights, or who exercise effective control over the company through other means. Where no individual holds more than 25%, the company's senior managing official (typically the legal representative/director) must be reported.

Who can access the UBO Register:

• Italian competent authorities — Guardia di Finanza, Agenzia delle Entrate, Bank of Italy — always have full, unrestricted access
• Obliged entities — banks, notaries, lawyers, accountants — access the register as part of mandatory client due diligence
• General public: access is restricted following the European Court of Justice Sovim ruling (Case C-601/20, November 2022), which held that unrestricted public access to UBO registers violates EU fundamental rights; Italy now requires demonstration of a "legitimate interest" for general public access — random online searches are not possible

Penalties for non-compliance: Administrative sanctions against both the company and its directors, potential fines, and the risk of triggering an AML investigation.

The EU AML Package (Regulation 2024/1624, adopted June 2024) will further tighten UBO disclosure obligations from 2027 onward. Any nominee structure designed now must account for this trajectory — the direction of EU law is toward greater, not lesser, beneficial ownership transparency.

Nominee Director vs. Nominee Shareholder — Legal Structures

Italian law recognizes both nominee director and nominee shareholder structures, but they operate under different legal frameworks with different licensing requirements.

Nominee Director (Amministratore Fiduciario):

The legal basis is the mandato (mandate agreement, Arts. 1703–1730 Italian Civil Code) combined with a procura (power of attorney) from the beneficial owner to the nominee director. The nominee director is formally appointed in the SRL's deed of incorporation or by shareholder resolution and appears in the Registro delle Imprese as the company's director.

The mandate agreement between the beneficial owner and nominee defines the scope of the nominee's authority, the instructions they must follow, the indemnification terms, and the termination conditions. However, this mandate agreement binds only the parties to it. Third parties — banks, suppliers, regulators — deal with the nominee director according to their actual legal authority within the SRL's governance documents, not according to the private mandate's restrictions. The nominee can legally bind the company within the scope of their corporate authority regardless of any private instruction to the contrary.

Nominee Shareholder (Intestazione Fiduciaria):

Nominee shareholder arrangements operate under a fundamentally different and more regulated framework. The legal basis is fiduciary share-holding under Legge 23 novembre 1939, n. 1966, Italy's foundational fiduciary law. Only entities licensed by MIMIT under this law can legally hold shares as fiduciary nominees in Italy.

This is the most important compliance distinction: using an unlicensed individual — a friend, a lawyer acting outside their professional role, or a company without the MIMIT license — to hold shares on a nominee basis creates serious legal and tax risks. The arrangement may be characterized as a simulazione (sham transaction), with consequences including void share transfers, personal tax liability for undisclosed income, and potential AML exposure. Approximately 200+ licensed società fiduciarie exist in Italy.

A shareholders' agreement (patto parasociale) can operate alongside both structures to define the beneficial owner's rights, voting instructions, and exit mechanisms. Under Art. 2341-bis of the Italian Civil Code, patti parasociali in SRLs have a maximum statutory duration of five years.

Opening an Italian bank account requires presenting the full nominee arrangement documentation to the bank's compliance and KYC team — this is where improperly structured arrangements are most frequently challenged.

Director Liability Under Italian Law

Understanding director liability is essential for understanding why nominee director fees are significantly higher than a standard employment or service contract would suggest.

Art. 2392 Italian Civil Code imposes joint and several liability on company directors for damages caused to the company by failure to act with the diligence of a reasonably prudent professional (diligenza del mandatario). This liability applies to nominee directors in exactly the same way it applies to operational directors — there is no carve-out, no exemption, and no reduced standard because the directorship is "nominee" rather than operational.

A nominee director who signs a commercial contract on the company's behalf, fails to prevent a regulatory violation, or oversees a period during which the company incurs undisclosed tax liabilities faces precisely the same personal liability exposure as a direct operational director. This is not theoretical — Italian courts regularly pursue director liability claims.

This genuine legal exposure drives the fee premium associated with nominee directors. A nominee director charging €3,000–€15,000+ per year is pricing in: professional liability premium for absorbing real legal risk on behalf of the beneficial owner; AML compliance obligations, including UBO Register filing responsibilities; time required for actual management decisions the nominee must make to avoid a nominal-directorship challenge; and professional indemnity insurance coverage.

The mandate agreement between nominee and beneficial owner typically includes indemnification provisions — the beneficial owner agrees to indemnify the nominee against third-party claims arising from proper execution of the mandate. These indemnities are contractually binding between the parties but cannot be asserted against Italian courts, tax authorities, or creditors who pursue the nominee directly.

Simulazione avoidance is a critical structural consideration. A purely nominal directorship — where the nominee takes no actual management actions, never reviews company decisions, and performs zero oversight — increases the risk of a court characterizing the arrangement as a sham designed to circumvent legal obligations. A properly structured nominee directorship involves genuine, documented management activity within the mandate's scope.

Timeline Reality Check — From Engagement to Operational

Foreign entrepreneurs underestimate how long the full nominee setup process takes, particularly when an Italian bank account must be opened.

Step 1 — Mandate and Fiduciary Agreement Drafting. Legal review of the mandate agreement and (for shareholder arrangements) fiduciary agreement takes 5–10 working days. Both documents require careful drafting to reflect the actual scope of the arrangement and comply with current AML obligations.

Step 2 — Notarial Deed or Shareholder Resolution. Appointing the nominee director formally requires either incorporation documents (if at formation) or a notarial deed of shareholder resolution (for post-incorporation appointment). If shareholders are abroad, apostilled and certified-translated powers of attorney must be prepared first. Timeline: 1–3 weeks, longer if apostille processing from the home country is slow.

Step 3 — Codice Fiscale for Foreign Beneficial Owner. The beneficial owner must hold an Italian codice fiscale (tax identification number) for UBO Register filing purposes. If not already held, timeline: 1–5 working days.

Step 4 — CCIAA Registration. The nominee director's appointment must be registered with the Registro delle Imprese within 30 days of appointment. Filing fee: €90–€200. Processing: 5–10 working days.

Step 5 — UBO Register Filing. Must be completed within 30 days of company formation. Filed simultaneously with CCIAA registration in most cases.

Step 6 — Bank Account Opening. This is consistently the primary bottleneck in the entire process. Italian banks require full beneficial ownership documentation, AML questionnaires, business plan summaries, source-of-funds explanations, and often a management meeting. For foreign-owned SRLs with nominee structures, bank account opening takes 4–12 weeks — longer for higher-risk sectors or complex multi-layer structures.

Total realistic timeline: 6–16 weeks from engagement to a fully operational company with an active bank account.

Costs — What You Are Actually Paying For

Nominee service costs reflect the genuine professional risk, compliance obligations, and time commitments involved — not an arbitrage on a simple secretarial function.

The nominal/operational divide within nominee director fee structures: a nominee who takes no genuine management action charges a lower fee but carries higher simulazione risk; a nominee who actively participates in governance decisions — reviewing contracts, attending board meetings, countersigning regulatory filings — charges a higher fee but produces a more defensible arrangement.

Annual renewal: most nominee arrangements require annual renewal of the mandate agreement, UBO re-confirmation with MIMIT, and payment of the ongoing service fee. Failure to renew properly creates both legal ambiguity in the nominee relationship and potential UBO Register non-compliance.

Costs increase with: complex multi-layer corporate structures involving multiple shareholders; high-risk sectors (financial services, crypto, regulated activities); active trading requiring frequent director decisions; banks requiring annual KYC update meetings; and nominee shareholder arrangements for companies that receive significant third-party investment.

Nominee arrangements are most effectively structured at SRL incorporation — retroactive implementation after a company has been operating creates additional complexity and cost.

FAQ

Q: Is a nominee director legal in Italy?

Yes. Nominee director arrangements based on a mandate agreement (mandato, Arts. 1703–1730 Italian Civil Code) are fully legal in Italy. They are subject to Italy's mandatory UBO Register requirements (since October 2023) and EU AML obligations — the beneficial owner must always be disclosed to Italian authorities — but the service itself is lawfully provided and widely used by foreign entrepreneurs for legitimate commercial privacy purposes.

Q: Does Italy have a public register of beneficial owners?

Yes. Italy's Registro dei Titolari Effettivi became operational in October 2023 and requires all Italian companies to disclose their ultimate beneficial owners (individuals holding more than 25% or exercising effective control) within 30 days of formation. Italian authorities and financial institutions have full access. General public access is restricted following the ECJ Sovim ruling — random online lookup is not possible, but institutional access is unrestricted.

Q: Can a foreigner be a director of an Italian SRL?

Yes. There is no residency or nationality requirement for an SRL director under Italian corporate law. The director must obtain an Italian codice fiscale and register with the Registro delle Imprese within 30 days of appointment. Practically, a non-resident foreign director complicates bank account opening (extended KYC), INPS enrollment if the director is compensated, and daily operational management decisions that require same-day action.

Q: What is the difference between a nominee director and a nominee shareholder in Italy?

A nominee director is appointed via a mandate agreement (Arts. 1703–1730 CC) and appears as the company's director in the Registro delle Imprese, with the beneficial owner retaining control through private mandate instructions. A nominee shareholder holds shares via a MIMIT-licensed società fiduciaria under Law 1966/1939 — only entities with this specific MIMIT license can legally provide fiduciary share-holding in Italy. Using an unlicensed individual for share-holding creates simulazione risk and potential tax and AML liability.

Q: Do I still have to disclose my identity if I use a nominee in Italy?

Yes. Regardless of nominee arrangements, all beneficial owners — natural persons controlling more than 25% or exercising effective control through any means — must be declared to Italy's UBO Register (Registro dei Titolari Effettivi) within 30 days of company formation. Italian authorities — Guardia di Finanza, Agenzia delle Entrate, Bank of Italy — always have full access to this information. Nominee services provide commercial privacy from the general public and business counterparties, not regulatory anonymity from state authorities.

Ready to Get Started?

Italian nominee director and shareholder services are legitimate, legally structured, and commercially valuable — provided they use MIMIT-licensed società fiduciarie for share-holding, properly disclose UBO information to Italy's mandatory register, and price in the genuine director liability premium under Art. 2392 CC. The key decision is which combination of nominee arrangements fits your situation: director-only, shareholder-only, or both — and whether the 6–16 week banking timeline fits your business entry plan.

Our lawyers in Milan, Rome, and Florence structure compliant nominee arrangements under the post-2023 Italian AML framework, including UBO Register filing, mandate agreement drafting, and bank account opening support. Contact us to arrange a consultation.

Milan: Via Monte Napoleone 8, 20121 Milano — +39 02 8088 1240 Rome: Via del Corso 184, 00186 Roma — +39 06 4520 7330 Florence: Via de' Tornabuoni 17, 50123 Firenze — +39 055 264 8120 Email: info@company-italy.com

This page provides general information about nominee director and shareholder services in Italy and does not constitute legal or financial advice. Nominee structures are subject to mandatory AML and UBO disclosure obligations. Consult our qualified Italian legal team for guidance specific to your situation.